Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment
Clinical trial NCT04363216 · UNKNOWN
Trial details
- NCT number
- NCT04363216
- Sponsor
- Thomas Jefferson University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-01
- Primary completion
- 2021-05-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.